Cells-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2021-08-05 krygios

偏重的研究方向：分子生物学
经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？

89 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2023-03-06 ms3000001848957428 来自广东省

接收交了钱后拖了几个月又给拒了，真是无语。

52 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2023-03-17 ms5000002045444786 来自山东省

23年是不是不收综述了，今年还没有综述发表，投了综述一直under review

56 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2023-02-15 1581ff5fd7m 来自山东省

审稿速度:3.0 | 投稿命中率:75.0
经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月

61 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2023-01-02 ms4000000974863257 来自江西省

偏重的研究方向：肠道菌群
经验分享：Under review到底送外审了嘛

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2022-07-23 ms3000000915988761

偏重的研究方向：细胞信号;分子生物学
经验分享：Under review 是外审还是编辑内审？

71 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2022-11-24 ms8000000030832967 来自重庆

拒稿鼓励重投，这种有机会吗

35 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2020-05-06 121f1bc9m90(暂无昵称)

该杂志对中国医院的论文有歧视

152 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2022-12-13 庸医小郝来自湖北省

Pending review三天了，这么慢吗，这是在分配编辑嘛？

51 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1005299, encodeId=c6621005299cc, content=偏重的研究方向：分子生物学 经验分享：收到这个杂志特刊主编的邀稿，基于之前对中国医院的歧视，邮件转问杂志全职编辑，回复欢迎投稿，给予折扣，有哪位知道这个杂志邀稿比普通投稿有接收优势不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Aug 05 09:53:01 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117974, encodeId=d717211e9743e, content=接收交了钱后拖了几个月又给拒了，真是无语。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b856527928, createdName=ms3000001848957428, createdTime=Mon Mar 06 19:16:09 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2120167, encodeId=d351212016e1b, content=23年是不是不收综述了，今年还没有综述发表，投了综述一直under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9eb96575201, createdName=ms5000002045444786, createdTime=Fri Mar 17 17:04:06 CST 2023, time=2023-03-17, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2114802, encodeId=b2d6211480267, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：返修后迟迟不给回复，反复催了多次，最后拒稿，返回的意见发现审稿专家两个月之前就给出了，只是编辑迟迟没有下决定。耽误了宝贵两个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/b3a4bbf05ce5b57e54be1656c69af706.jpg, createdBy=b0c82143400, createdName=1581ff5fd7m, createdTime=Wed Feb 15 21:33:37 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2108500, encodeId=1093210850071, content=偏重的研究方向：肠道菌群 经验分享：Under review到底送外审了嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e516151213, createdName=ms4000000974863257, createdTime=Mon Jan 02 13:15:56 CST 2023, time=2023-01-02, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1234171, encodeId=f3e012341e115, content=偏重的研究方向：细胞信号;分子生物学 经验分享：Under review 是外审还是编辑内审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=581a8113734, createdName=ms3000000915988761, createdTime=Sat Jul 23 08:56:02 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102494, encodeId=4b3e2102494fc, content=拒稿鼓励重投，这种有机会吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f448171940, createdName=ms8000000030832967, createdTime=Thu Nov 24 21:26:28 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=590324, encodeId=666b590324c5, content=该杂志对中国医院的论文有歧视, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2c352294221, createdName=121f1bc9m90(暂无昵称), createdTime=Wed May 06 13:35:00 CST 2020, time=2020-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105899, encodeId=bb6e210589936, content=Pending review三天了，这么慢吗，这是在分配编辑嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230516/a5876ef59b2b4825ad581eb6cfd86daf/6ba028f9262342b795ff62bc10dacb71.png, createdBy=22bd5254581, createdName=庸医小郝, createdTime=Tue Dec 13 20:36:40 CST 2022, time=2022-12-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2105352, encodeId=439d210535264, content=投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人 这样还有戏吗（叹气）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8332469177, createdName=12433741m11(暂无昵称), createdTime=Sun Dec 11 12:37:19 CST 2022, time=2022-12-11, status=1, ipAttribution=湖北省)]

2022-12-11 12433741m11(暂无昵称) 来自湖北省

投稿后初审，两个审稿人意见还好（审稿人1：接受前需要做出一些必要的修改；审稿人2：我同意接收，但需要一些改动），状态持续pending decision半个多月（这个状态似乎是不乐观？），然后状态又突然变回under review，编辑说是在寻找第三个审稿人
这样还有戏吗（叹气）

45 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务